EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION Report on the Risk Assessment of GHB in the Framework of the Joint Action on New Synthetic Drugs

EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION Report on the Risk Assessment of ketamine in the Framework of the Joint Action on New Synthetic Drugs

ECDC and EMCDDA joint guidance report on reducing infections among people who inject drugs.

On 12 October 2011, the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published a joint guidance on the prevention and control of infectious diseases among people who inject drugs [1]. The two agencies of the European Union (EU) bring together know-how from the fields of drugs and infections, assess the evidenc...

Qualitative Study of Addiction in Beauty Salons and Sports Gyms

Aim: The Spread of a New Trend in Drugs Advertisement in the Recent Years Has Caused a Hike in Addiction among Women in High-Risk Cases Such as Hallucinogenic and Stimulating Drugs. Distribution and Advertisement for Synthetic Drugs in Beauty Salons and Gyms Have Been Implicated in This Hike. With the Aim of Investigating This Claim, the Present Research Has Engaged in the Qualitative Study of ...

A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs

Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and significant inter-individual variability in blood concentrations. This variability can be because of factors like drug-nutrient interactions, drug-disease interactions, renal-insufficiency, inflammation and infection, gender, age, polymorphism and liver mass. Drug monitoring is widely practiced ...

EMCDDA publishes 2012 report on the state of the drugs problem in Europe.

Today, 15 November 2012, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon, published its 17th annual report on the state of the drugs problem in Europe. In this year's report, the Centre raises concerns over a complex stimulant market with a diversity of powders and pills used today. While cocaine, ecstasy and amphetamines continue to be the main stimulants used, t...